基本信息
views: 30
Career Trajectory
Bio
I am a senior research fellow at Center for Stem Cell and Translational Immunotherapy (CSTI) at Brigham and Women's Hospital, Harvard Medical School. I joined CSTI in 2019 after finishing my M.D. and Ph.D. degrees. I have been engaged in a translational research on oncolytic virus (OV) against solid tumors since I was a Ph.D. student in Okayama university. At CSTI, my projects are to focus on the development of novel combination therapy with OV-armed stem cell (SC) and SC secreting immunomodulators for advanced melanoma. Prior to joining CSTI, I also worked on clinical trials with oncolytic adenovirus (UMIN000010158, NCT03172819) as well as performed research on combination therapy with oncolytic virus and immune checkpoint inhibitors. My goal is to become an excellent academic surgeon in the future.
Research Interests
Papers共 68 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 6_Supplement (2024): 3720-3720
Susana Moleirinho,Yohei Kitamura, Paulo S. G. N. Borges,Sophia Auduong, Seyda Kilic,David Deng,Nobuhiko Kanaya,David Kozono, Jing Zhou, Jeffrey J. Gray,Esther Revai-Lechtich,Yanni Zhu,Khalid Shah
Stem cells translational medicineno. 7 (2024): 444-458
Masashi Hashimoto,Shinji Kuroda,Nobuhiko Kanaya, Daisuke Kadowaki, Yusuke Yoshida,Masaki Sakamoto,Yuki Hamada,Ryoma Sugimoto,Chiaki Yagi, Tomoko Ohtani,Kento Kumon,Yoshihiko Kakiuchi,Kazuya Yasui,Satoru Kikuchi,Ryuichi Yoshida,Hiroshi Tazawa,Shunsuke Kagawa,Takahito Yagi,Yasuo Urata,Toshiyoshi Fujiwara
British journal of cancerno. 10 (2024): 1716-1717
Expert opinion on therapeutic targetsno. 9 (2023): 1-10
CANCER RESEARCHno. 7 (2023)
Neuro-oncologyno. Supplement_5 (2023): v223-v223
Load More
Author Statistics
#Papers: 68
#Citation: 544
H-Index: 15
G-Index: 22
Sociability: 5
Diversity: 3
Activity: 27
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn